<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC6857389\results\search\disease\results.xml">
  <result pre="Prim CareJ Family Med Prim CareJFMPCJournal of Family Medicine and" exact="Primary" post="Care2249-48632278-7135Wolters Kluwer - MedknowIndia JFMPC-8-3125 doi: 10.4103/jfmpc.jfmpc_716_19 : Review"/>
  <result pre="JFMPC-8-3125 doi: 10.4103/jfmpc.jfmpc_716_19 : Review Article A notorious vector-borne disease:" exact="Dengue" post="fever, its evolution as public health threat PathakVineet K.1MohanM1[1],"/>
  <result pre="the new creations are licensed under the identical terms. Abstract" exact="Dengue" post="fever, the most notorious of vector borne diseases is"/>
  <result pre="of dengue must be identified and intensified to control further" exact="disease" post="transmission as there is no specific antiviral treatment or"/>
  <result pre="is available in India. Aedes dengue epidemiology surveillance urbanization Background" exact="Dengue" post="virus (DENV) is a positive-stranded encapsulated RNA virus of"/>
  <result pre="and also by Aedes albopictus.[2] Aedes Aegypti also transmits Chikungunya," exact="yellow fever," post="and Zika infections.[1] Dengue also referred to as â€œwater"/>
  <result pre="Aedes Aegypti also transmits Chikungunya, yellow fever, and Zika infections.[1]" exact="Dengue" post="also referred to as â€œwater poison,â€� â€œcramp-like seizure,â€� or"/>
  <result pre="or â€œbreak bone feverâ€�[2] is the most rapidly spreading mosquito-borne" exact="viral" post="disease in the world. In the last 50 years,"/>
  <result pre="â€œbreak bone feverâ€�[2] is the most rapidly spreading mosquito-borne viral" exact="disease" post="in the world. In the last 50 years, incidence"/>
  <result pre="along with geographic expansion. Although only nine countries had experienced" exact="severe dengue" post="epidemics prior to 1970, the disease is now endemic"/>
  <result pre="countries had experienced severe dengue epidemics prior to 1970, the" exact="disease" post="is now endemic in more than 120 countries and"/>
  <result pre="and an estimated 3.9 billion people are at risk of" exact="infection" post="with DNVs, with nearly 400 million infections occurring annually.[13]"/>
  <result pre="at risk of infection with DNVs, with nearly 400 million" exact="infections" post="occurring annually.[13] This significant public health threat is no"/>
  <result pre="and in 2014, Japan reported its first outbreak of the" exact="disease" post="in 70 years.[5] With global resurgence, it is imperative"/>
  <result pre="and Ovid. This report gives a comprehensive understanding of the" exact="disease" post="and its management, the knowledge of which is a"/>
  <result pre="knowledge of which is a prime importance to practice of" exact="primary" post="healthcare. Realizing the importance Government of India has named"/>
  <result pre="importance Government of India has named 16th May 2019 â€œNational" exact="Dengue" post="day.â€� The theme was â€œFight the bite: Prevent Dengueâ€�"/>
  <result pre="which again signifies the importance of prevention and role of" exact="primary" post="healthcare providers.[6] Epidemiology of Dengue Virus The epidemiology of"/>
  <result pre="of prevention and role of primary healthcare providers.[6] Epidemiology of" exact="Dengue" post="Virus The epidemiology of dengue significantly changed in south-east"/>
  <result pre="severity of disease. The very first report of existence of" exact="dengue fever" post="in India was way back in 1946.[8] Notable epidemics"/>
  <result pre="cocirculate thus changing it to a hyperendemic state,[13] followed by" exact="complete" post="predominance of DEN serotype 3 in 2005.[1415] Further, replacement"/>
  <result pre="Cocirculation of several serotypes of DNVs has resulted in concurrent" exact="infection" post="in some patients with multiple serotypes of DEN.[18] Concurrent"/>
  <result pre="infection in some patients with multiple serotypes of DEN.[18] Concurrent" exact="infection" post="by Chikungunya and DEN-2 was reported from Vellore and"/>
  <result pre="and DEN-2 was reported from Vellore and Delhi.[1920] Transmission cycle" exact="Infection" post="with DNVs is transmitted through the bite of infective"/>
  <result pre="cycle Infection with DNVs is transmitted through the bite of" exact="infective" post="female Aedes spp. Mosquitoes.[21] Aedes Aegypti, the principal vector,"/>
  <result pre="Infection with DNVs is transmitted through the bite of infective" exact="female" post="Aedes spp. Mosquitoes.[21] Aedes Aegypti, the principal vector, that"/>
  <result pre="(average 4 to 6 days), the person may experience an" exact="acute" post="onset of fever accompanied by a variety of nonspecific"/>
  <result pre="by a variety of nonspecific signs and symptoms. During this" exact="acute" post="febrile period, there is a viremia, which may vary"/>
  <result pre="with an extrinsic incubation period of 8 to 12 days" exact="Viral" post="interhost variation In humans, infection with DNV results in"/>
  <result pre="of 8 to 12 days Viral interhost variation In humans," exact="infection" post="with DNV results in a spectrum of clinical outcomes,"/>
  <result pre="in a spectrum of clinical outcomes, ranging from self-limiting, uncomplicated" exact="dengue fever" post="(characterized by a sudden onset of fever and one"/>
  <result pre="arthralgia, nausea and vomiting, weakness, and rash) to the more" exact="severe dengue" post="hemorrhagic fever (DHF). The critical stage in DHF is"/>
  <result pre="nausea and vomiting, weakness, and rash) to the more severe" exact="dengue hemorrhagic fever" post="(DHF). The critical stage in DHF is at the"/>
  <result pre="signs of circulatory failure and hemorrhagic manifestations, primarily skin hemorrhages," exact="thrombocytopenia" post="(&amp;lt;100 000/mm3), and elevated hematocrit being the prominent features."/>
  <result pre="most severe cases, these hemorrhagic manifestations lead to potentially fatal" exact="hypovolemic shock," post="a condition known as dengue shock syndrome. Infection with"/>
  <result pre="lead to potentially fatal hypovolemic shock, a condition known as" exact="dengue shock syndrome." post="Infection with one serotype of DENV confers short-lived immunity"/>
  <result pre="fatal hypovolemic shock, a condition known as dengue shock syndrome." exact="Infection" post="with one serotype of DENV confers short-lived immunity against"/>
  <result pre="the previous instead of the current serotype, leading to increased" exact="viral" post="replication.[24] Factors responsible for global resurgence of dengue The"/>
  <result pre="indoor wastes as a study reported that 79% of the" exact="total" post="breeding sites was indoor in Singapore.[28] Transportation and migration:"/>
  <result pre="of virus which makes it more difficult to control the" exact="infection" post="spread. Hence, tourism and immigration are risk factors of"/>
  <result pre="insecticide resistance. The ability of larvicides to control vectors also" exact="limited" post="as it has low coverage in term of the"/>
  <result pre="that after application of the ultralow volume, the population of" exact="adult" post="mosquitoes returned to the pretreatment level within 2 weeks"/>
  <result pre="impact resulted was minimal.[28] Public perception: Although community participation in" exact="disease" post="control is crucial, but often public perceives that dengue"/>
  <result pre="studies revealed that people from dengue endemic countries understand the" exact="disease" post="and its transmission, but the control practices are not"/>
  <result pre="shown to have less impact on behavioral and entomologic indices" exact="Limited" post="infrastructure and resources: National Vector Borne Disease Control Program"/>
  <result pre="and entomologic indices Limited infrastructure and resources: National Vector Borne" exact="Disease" post="Control Program (NVBDCP) covers malaria, dengue, Chikungunya, and Japanese"/>
  <result pre="Borne Disease Control Program (NVBDCP) covers malaria, dengue, Chikungunya, and" exact="Japanese encephalitis," post="and also works for the elimination of Kala-azar and"/>
  <result pre="resulting in subsequent increase in vector's population. Other factors include" exact="limited" post="infrastructure and resources in control and surveillance, limited quality"/>
  <result pre="factors include limited infrastructure and resources in control and surveillance," exact="limited" post="quality of diagnosis, and clinical care and the need"/>
  <result pre="entomological tools to standardize and classify the vectors. Surveillance in" exact="dengue fever" post="Surveillance is a prerequisite for monitoring the dengue situation"/>
  <result pre="by laboratory, others would be considered epidemiologically linked cases. However," exact="atypical" post="cases (doubtful) samples must be sent for laboratory confirmation."/>
  <result pre="containers for Aedes Aegypti per 100 houses) are usually used." exact="Adult" post="mosquito surveillance will help in finding out the susceptibility"/>
  <result pre="Hospitals from fever of unknown origin for serological surveillance and" exact="viral" post="detection for setting up of early warning signals for"/>
  <result pre="transmission. Treatment and prevention There is no specific treatment for" exact="dengue fever" post="or for severe dengue though medical care by experienced"/>
  <result pre="There is no specific treatment for dengue fever or for" exact="severe dengue" post="though medical care by experienced physicians and nurses has"/>
  <result pre="Maintenance of the patient's body fluid volume is critical to" exact="severe dengue" post="care.[30] At present, the main method to control or"/>
  <result pre="Communication Facilities should be provided for easy communication, especially between" exact="secondary" post="and tertiary levels of care and laboratories, including consultation"/>
  <result pre="tertiary levels of care and laboratories, including consultation by telephone." exact="Blood" post="bank Blood and blood products will be required by"/>
  <result pre="of care and laboratories, including consultation by telephone. Blood bank" exact="Blood" post="and blood products will be required by only a"/>
  <result pre="makers, prevention of dengue must be intensified to control further" exact="disease" post="transmission as there is no specific antiviral treatment or"/>
  <result pre="interest There are no conflicts of interest. References 1Dengue and" exact="severe dengue" post="[Internet]cited 2019 Jul 02Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue 2GuptaNSrivastavaSJainAChaturvediUDengue in IndiaIndian"/>
  <result pre="present, and scenarios for the futureLancet Infect Dis20141412718025172160 5KutsunaSKatoYMoiMLKotakiAOtaMShinoharaKet al.Autochthonous" exact="dengue fever," post="Tokyo, Japan, 2014Emerg Infect Dis2015215172025695200 6National Dengue Day 2019"/>
  <result pre="5KutsunaSKatoYMoiMLKotakiAOtaMShinoharaKet al.Autochthonous dengue fever, Tokyo, Japan, 2014Emerg Infect Dis2015215172025695200 6National" exact="Dengue" post="Day 2019 | National Health Portal of India [Internet]cited"/>
  <result pre="2014Emerg Infect Dis2015215172025695200 6National Dengue Day 2019 | National Health" exact="Portal" post="of India [Internet]cited 2019 Sep 18Available from: https://www.nhp.gov.in/national-dengue-day-2019_pg 7GublerDJEpidemic"/>
  <result pre="incidence of DHF and DSSVirol J200635516824209 16ChakravartiAKumarAMatlaniMDisplacement of dengue virus" exact="type 3" post="and type 2 by dengue virus type 1 in"/>
  <result pre="and DSSVirol J200635516824209 16ChakravartiAKumarAMatlaniMDisplacement of dengue virus type 3 and" exact="type 2" post="by dengue virus type 1 in Delhi during 2008Indian"/>
  <result pre="dengue virus type 3 and type 2 by dengue virus" exact="type 1" post="in Delhi during 2008Indian J Med Microbiol201028412 17KukretiHChaudharyARautelaRSAnandRMittalVChhabraMet al.Emergence"/>
  <result pre="Microbiol201028412 17KukretiHChaudharyARautelaRSAnandRMittalVChhabraMet al.Emergence of an independent lineage of dengue virus" exact="type 1" post="(DENV-1) and its co-circulation with predominant DENV-3 during the"/>
  <result pre="(DENV-1) and its co-circulation with predominant DENV-3 during the 2006" exact="dengue fever" post="outbreak in DelhiInt J Infect Dis200812542918495513 18BharajPChaharHSPandeyADiddiKDarLGuleriaRet al.Concurrent infections"/>
  <result pre="dengue fever outbreak in DelhiInt J Infect Dis200812542918495513 18BharajPChaharHSPandeyADiddiKDarLGuleriaRet al.Concurrent" exact="infections" post="by all four dengue virus serotypes during an outbreak"/>
  <result pre="of dengue in 2006 in Delhi, IndiaVirol J20085118182120 19ChaharHSBharajPDarLGuleriaRKabraSKBroorSCo-infections with" exact="chikungunya" post="virus and dengue virus in Delhi, IndiaEmerg Infect Dis20091510778019624923"/>
  <result pre="Viremia in manAm J Trop Med Hyg198130109497283006 23GublerDJMonathTPDengueEpidemiology of Arthropod-Borne" exact="Viral" post="Disease1988IIChapter 23Boca Raton, FL, USACRC Press Inc22360 24ChanKROngEZTanHCZhangSL-XZhangQTangKFet al.Leukocyte"/>
  <result pre="prevention and controlCad Saude Publica200925S193119287863 29Budget : National Vector Borne" exact="Disease" post="Control Programme (NVBDCP) [Internet]cited 2019 Jul 02Available from: https://nvbdcp.gov.in/index1.php?lang=1&amp;amp;level=1&amp;amp;sublinkid=5796and"/>
  <result pre="review of the evidencePLoS Negl Trop Dis20148e284824810901 34MurhekarMJoshuaVKanagasabaiKSheteVRaviMRamachandranRet al.Epidemiology of" exact="dengue fever" post="in India, based on laboratory surveillance data, 2014-2017Int J"/>
  <result pre="from: https://linkinghub.elsevier.com/retrieve/pii/S1201971219300153 35RajapakseSRodrigoCRajapakseTreatment of dengue feverInfect Drug Resist201251031222870039 36WHO |" exact="Dengue" post="guidelines for diagnosis, treatment, prevention and control: New edition"/>
 </snippets>
</snippetsTree>
